References
- Kligman A M, Grove G L, Hirose R, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15: 836–59
- Weiss J S, Ellis C N, Headington JT, et al. Topical tretinoin improves photodamaged skin: a double-blind vehicle-controlled study. J Am Med Assoc 1988; 259: 527–32
- Leyden J J, Grove G, Thome EG, et al. Treatment of photodamaged facial skin with topical tretinoin. J Am Acad Dermatol 1989; 21: 638–45
- Weinstein G D, Nigra T P, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin: a multicenter study. Arch Dermatol 1991; 127: 659–65
- Olsen E A, Katz I, Levine N, et al. Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol 1992; 26: 215–24
- Rafal E S, Griffiths C EM, Ditre CM, et al. Topical tretinoin (retinoic acid) for treatment for liver spots associated with photodamage. N Engl J Med 1992; 326: 368–374
- Griffiths C EM, Goldfarb M T, Finkel LJ, et al. Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. J Am Acad Dermatol 1994; 30: 76–84
- Orfanos C E, Mahrle G, Goerz G, et al. Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. Dermatologica 1979; 159: 62–70
- Uitto J, Olsen DR. Retinoid modulation of cutaneous extracellular matrix gene expression. Karger, Basel 1989; vol 3
- Chen S, Beehler B, Sugimoto G, et al. Effects of all-transretinoic acid on glycosaminoglycan synthesis in photodamaged hairless mouse skin. J Invest Dermatol 1993; 101: 237–9
- Chen S, Kiss I, Tramposch KM. Effects of all-trans retinoic acid on UVB-irradiated and non-irradiated hairless mouse skin. J Invest Dermatol 1992; 98: 248–54
- Kligman LH. Skin changes in photoaging: characteristics, prevention, and repair. Raven Press, New York 1989
- Bissett D L, Chatterjee R, Hannon DP. Protective effects of a topically applied antioxidant plus an antiinflammatory agent against ultraviolet radiation induced chronic skin damage in the hairless mouse. J Soc Cosmet Chem 1992; 43: 85–92
- Kestel J L, Jr. Hypopigmentation following the use of Cordran tape. Arch Dermatol 1971; 103: 460
- Arnold J, Anthonioz P, Marchand JP. Depigmenting action of corticosteroids. Experimental study on guinea pigs. Dermatologica 1975; 151: 274–9
- Orlow S J, Chakraboty A K, Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990; 94: 461–4
- Lesnik R H, Mesick J A, Capeota R, et al. Topical all-transretinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect. J Am Acad Dermatol 1989; 21: 186–90
- Schwartz E, Mezick J A, Gendimenico GJ, et al. In vivo prevention of corticosteroid-induced skin atrophy by tretinoin in the hairless mouse is accompanied by modulation of collagen, glycosaminoglycans, and fibronectin. J Invest Dermatol 1994; 102: 241–6
- Schmied C, Saurat J-H. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans. Dermatologica 1991; 182: 107–11
- De Lacharriere O, Escoffier C, Gracia A-M, et al. Reversal effects of topical retinoic acid on the skin of kidney transplant recipients under systemic corticotherapy. J Invest Dermatol 1990; 95: 516–22
- Griffiths C EM, Wang T S, Hamilton TA, et al. A photomeric scale for the assessment of cutaneous photodamage. Arch Dermatol 1992; 128: 347–51